Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
08/29/20175:30AMBusiness WireJazz Pharmaceuticals & ImmunoGen, Inc. Announce a Strategic Collaboration & Option Agreement to Develop & Commercialize Antib...NASDAQ:IMGNImmunoGen Inc
08/29/20175:30AMPR Newswire (US)Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize...NASDAQ:IMGNImmunoGen Inc
08/29/20175:30AMPR Newswire (US)Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize...NASDAQ:IMGNImmunoGen Inc
08/28/20178:51AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:IMGNImmunoGen Inc
08/07/20173:58PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:IMGNImmunoGen Inc
08/04/20173:32PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMGNImmunoGen Inc
08/04/20173:27PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMGNImmunoGen Inc
08/04/20173:21PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
08/01/20173:30PMBusiness WireImmunoGen Announces Webcast of Presentation at the Canaccord Genuity Growth ConferenceNASDAQ:IMGNImmunoGen Inc
07/28/20175:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
07/28/20175:30AMBusiness WireImmunoGen Reports Recent Progress and Second Quarter 2017 Operating ResultsNASDAQ:IMGNImmunoGen Inc
07/14/20177:00AMBusiness WireImmunoGen Announces Conference Call to Discuss Its Second Quarter 2017 Financial ResultsNASDAQ:IMGNImmunoGen Inc
07/03/20177:14AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/03/20177:14AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/03/20177:14AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/03/20177:13AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/26/20177:00AMBusiness WireImmunoGen Presents Data from Phase I Study of IMGN779 in Acute Myeloid LeukemiaNASDAQ:IMGNImmunoGen Inc
06/16/20177:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
06/15/20179:03AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/15/20179:02AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/15/20179:02AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/15/20179:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/15/20179:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/15/20179:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/15/20179:00AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/15/20178:59AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
05/30/20177:50AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
05/30/20177:30AMBusiness WireImmunoGen and Sanofi Amend License AgreementsNASDAQ:IMGNImmunoGen Inc
05/24/20177:30AMBusiness WireImmunoGen Announces Webcast of Presentation at the Jefferies Global Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
05/24/20171:00AMPR Newswire (US)Debiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset From ImmunoGenNASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN